Skip to main content

and
  1. Article

    Open Access

    Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression

    Novel therapeutic strategies are urgently required for osteosarcoma, given the early age at onset and persistently high mortality rate. Modern transcriptomics techniques can identify differentially expressed g...

    Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno in Cancer Gene Therapy (2024)

  2. Article

    Open Access

    Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages

    Katherine Sturgess, Eliza Yankova, M. S. Vijayabaskar, Tomoya Isobe in Leukemia (2023)

  3. Article

    Open Access

    Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism

    Neuroblastomas require novel therapies that are based on the exploitation of their biological mechanism. To address this need, we analyzed the DNA methylation and expression datasets of neuroblastomas, extract...

    Kentaro Watanabe, Shunsuke Kimura, Masafumi Seki, Tomoya Isobe, Yasuo Kubota in Oncogene (2022)

  4. Article

    Open Access

    Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia

    KMT2A-rearranged infant acute lymphoblastic leukemia (ALL) represents the most refractory type of childhood leukemia. To uncover the molecular heterogeneity of this disease, we perform RNA sequencing, methylation...

    Tomoya Isobe, Masatoshi Takagi, Aiko Sato-Otsubo, Akira Nishimura in Nature Communications (2022)

  5. Article

    Open Access

    Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets

    To elucidate the molecular pathogenesis of pediatric germ cell tumors (GCTs), we performed DNA methylation array analysis, whole transcriptome sequencing, targeted capture sequencing, and single-nucleotide pol...

    Yasuo Kubota, Masafumi Seki, Tomoko Kawai, Tomoya Isobe in Communications Biology (2020)

  6. Article

    Open Access

    Integrated multiomics analysis of hepatoblastoma unravels its heterogeneity and provides novel druggable targets

    Although hepatoblastoma is the most common pediatric liver cancer, its genetic heterogeneity and therapeutic targets are not well elucidated. Therefore, we conducted a multiomics analysis, including mutatome, ...

    Masahiro Sekiguchi, Masafumi Seki, Tomoko Kawai, Kenichi Yoshida in npj Precision Oncology (2020)

  7. No Access

    Article

    DNA methylation-based classification reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes

    Shunsuke Kimura, Masafumi Seki, Tomoko Kawai, Hiroaki Goto, Kenichi Yoshida in Leukemia (2020)

  8. No Access

    Article

    Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia

    Junko Takita, Seishi Ogawa and colleagues profile 121 cases of pediatric T cell acute lymphoblasic leukemia (T-ALL) and identify recurrent SPI1 (PU.1) gene fusions. They find that these SPI1 fusions correlated wi...

    Masafumi Seki, Shunsuke Kimura, Tomoya Isobe, Kenichi Yoshida in Nature Genetics (2017)

  9. No Access

    Article

    NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity

    Jun Yang and colleagues perform targeted sequencing of NUDT15 and identify loss-of-function variants associated with thiopurine intolerance. Functionally, they show that NUDT15 inactivates thiopurine metabolites,...

    Takaya Moriyama, Rina Nishii, Virginia Perez-Andreu, Wenjian Yang in Nature Genetics (2016)

  10. No Access

    Article

    Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes

    Pediatric anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) usually has a benign clinical course. A small fraction of patients with ALCL develops an aggressive clinical course; ho...

    Akihiro Hoshino, Keiko Nomura, Takeru Hamashima in International Journal of Hematology (2015)